Exploring the cost effectiveness of Mindfulness Based Cognitive Therapy for Cancer (MBCT-Ca)

Cost effectiveness of MBCT-Ca delivered in addition to treatment as usual (TAU) as compared with TAU alone: a pilot pragmatic randomised controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN23380065

Enrollment

120

Registered

2012-11-28

Start date

2012-11-30

Completion date

Unknown

Last updated

2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental health of post-treatment cancer patients Mental and Behavioural Disorders

Interventions

The intervention group will receive an 8 week Mindfulness Based Cognitive Therapy for Cancer (MBCT-Ca) course delivered in addition to usual treatment, whereas the control group will continue with the

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adult patients (aged 18 years and over) who have received (or who are currently receiving) active cancer treatment including surgery, chemotherapy, radiotherapy, hormone therapy or a combination of these within the last 12 months 2. Patients able to attend the course venue weekly to undertake MBCT-Ca

Exclusion criteria

Exclusion criteria: 1. Patients who have not been offered active treatment for their cancer i.e. those receiving only symptomatic care 2. Patients who are unable or unwilling to complete English language group sessions and questionnaires for reasons of literacy, language or cognitive impairment 3. Patients lacking capacity to give informed consent

Design outcomes

Primary

Measure	Time frame
The EQ-5D (EuroQol, 1990) will provide the primary outcome measure of effect required to generate Quality Adjusted Life Years (QALYs) and the CSRI will provide the primary outcome measure of cost. These measures will be used to calculate the cost per QALY to determine the probability that MBCT-Ca is cost-effective.	—

Secondary

Measure	Time frame
1. Number of eligible patients identified by the oncology teams 2. Proportion of patients prepared to accept entry to the randomised pilot study 3. Proportion considered appropriate for MBCT-Ca after orientation by the course teacher 4. Proportion of patients that complete the 8-week course of MBCT-Ca 5. Proportion of patients returning completed forms at each time point up to 4 months after intervention 6. Quantitative measure of quality of life and capabilities to include health related quality of life (HRQoL) assessed by EORTC-QLQ-QC30 and ICECAP-A. 7. Measure of anxiety and depression HADS 8. Measure of participant wellbeing - WHO-5 9. Self compassion short form (SCS-SF) 10. Five Facet Mindfulness Scale short form (FFMS-SF) 11. Teacher Competence Measure (MBI-TAC)	—

Measure

Time frame

1. Number of eligible patients identified by the oncology teams 2. Proportion of patients prepared to accept entry to the randomised pilot study 3. Proportion considered appropriate for MBCT-Ca after orientation by the course teacher 4. Proportion of patients that complete the 8-week course of MBCT-Ca 5. Proportion of patients returning completed forms at each time point up to 4 months after intervention 6. Quantitative measure of quality of life and capabilities to include health related quality of life (HRQoL) assessed by EORTC-QLQ-QC30 and ICECAP-A. 7. Measure of anxiety and depression HADS 8. Measure of participant wellbeing - WHO-5 9. Self compassion short form (SCS-SF) 10. Five Facet Mindfulness Scale short form (FFMS-SF) 11. Teacher Competence Measure (MBI-TAC)

—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026